Curing Death
  Recent News |  Archives |  Tags |  About |  Newsletter |  Submit News |  Advertise With Us |  Subscribe to CuringDeath.com RSS Fee Subscribe
New Articles
Researchers find clue to stopping breast-cancer metastasis 11/20/2008

Breaking BubR1 mimics genetic shuffle seen in cancer cells 11/20/2008

'Let the sunshine in' to protect your heart this winter 11/20/2008

The relative risk of brain cancer 11/18/2008

Breakthrough in cell-type analysis offers new ways to study development and disease 11/18/2008

Researchers identify toehold for HIV's assault on brain 11/18/2008

No protective effect on cancer from long-term vitamin E or vitamin C supplementation 11/18/2008

Novel 4-drug combination proves safe for lung cancer treatment 11/18/2008

Protein compels ovarian cancer cells to cannibalize themselves 11/17/2008

Scientists find cell pathway driving a deadly sub-type of breast cancer 11/17/2008

Tiny sacs released by brain tumor cells carry information that may guide treatment 11/17/2008

Proton therapy and concurrent chemotherapy may reduce bone marrow toxicity in advanced lung cancer 11/17/2008

Researchers develop a new way to study how breast cancer spreads 11/17/2008

Researchers ID molecule linked to aggressive cancer growth, spread 11/16/2008

How eating red meat can spur cancer progression 11/16/2008

Matching Pathogens To Their Antibodies: Could Lead To HIV Vaccine (10/18/2007)

Tags:
hiv, viruses, vaccines

The search for a vaccination against HIV has been in progress since 1984, with very little success. Traditional methods used for identifying potential cellular targets can be very costly and time-consuming.

The key to creating a vaccination lies in knowing which parts of the pathogen to target with which antibodies. A new study by David Heckerman and colleagues from Massachusetts General Hospital, publishing in PLoS Computational Biology, has come up with a way to match pathogens to their antibodies.

At the core of the human immune response is the train-to-kill mechanism in which specialized immune cells are sensitized to recognize small peptides from foreign pathogens (e.g., HIV). Following this sensitization, these cells are then activated to kill cells that display this same peptide. However, for sensitization and killing to occur, the pathogen peptide must be "paired up" with one of the infected person's other specialized immune molecules--an HLA (human leukocyte antigen) molecule. The way in which pathogen peptides interact with these HLA molecules defines if and how an immune response will be generated.

Heckerman's model uses ELISpot assays to identify HLA-restricted epitopes, and which HLA alleles are responsible for which reactions towards which pathogens. The data generated about the immune response to pathogens fills in missing information from previous studies, and can be used to solve a variety of similar problems.

The model was applied to data from donors with HIV, and made 12 correct predictions out of 16. This study, says David Heckerman, has "significant implications for the understanding of...vaccine development." The statistical approach is unusual in the study of HLA molecules, and could lead the way to developing an HIV vaccine.

Citation: Listgarten J, Frahm N, Kadie C, Brander C, Heckerman D (2007) A statistical framework for modeling HLA-dependent T cell response data. PLoS Comput Biol 3(10): e188. doi:10.1371/journal.pcbi.0030188

Note: This story has been adapted from a news release issued by the Public Library of Science

Renegade Motorhomes - Credit Cards - Mobile Phone - Credit Cards

Post Comments:

Search

  Archives |  Submit News |  Advertise With Us |  Contact Us |  Links
All contents © 2000 - 2009 Web Doodle, LLC. All rights reserved.
Web Doodle, LLC does not provide medical advice, diagnosis or treatment. Please read our disclaimer